77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting

SHANGHAI, May 28, 2023 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter) today announced that the updated results of Phase Ib study of its CSF-1R inhibitor Pimicotinib (ABSK021) in treating patients with advanced tenosynovial giant cell tumor (“TGCT”), will

Read More

Credits roll on two weeks of unforgettable creations inspired by Campari, at 76th Festival de Cannes

CANNES, France, May 28, 2023 /PRNewswire/ — As an official partner to the 76th edition of the world-renowned Festival de Cannes, Campari, the icon of cocktail culture inspired through a series of events that celebrated the unforgettable creations of mixology

Read More

Big Data Expo 2023: Merging Digital Technology with Culture

GUIYANG, China, May 28, 2023 /PRNewswire/ — A news report by The much-awaited Big Data Expo 2023, taking place from May 26th to 28th in Guiyang, presents an array of groundbreaking technological accomplishments that are redefining the nexus of

Read More